Position in GSK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,813,905
-$149,135 QoQ
Shares Held
53,680
-0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#209
of 1,033 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PHILADELPHIA TRUST CO holds $76,830,601 across 11 Drug Manufacturers - General names. GSK ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
150,654 | $37,910,572 | |
| 2 | AMGN |
Amgen Inc
|
36,796 | $13,324,567 | |
| 3 | JNJ |
Johnson & Johnson
|
30,688 | $7,793,831 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,416 | $6,735,456 | |
| 5 | LLY |
ELI LILLY & Co
|
3,859 | $4,628,600 | |
| 6 | GSK |
GSK plc
This page
|
53,680 | $2,813,905 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,425 | $1,464,988 | |
| 8 | PFE |
Pfizer Inc
|
37,095 | $893,247 |
All Filings in GSK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,813,905 | 53,680 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,963,040 | 53,688 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,632,859 | 53,688 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,853,566 | 66,116 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,539,776 | 66,140 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,587,212 | 66,784 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,262,693 | 66,904 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,814,383 | 68,845 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,778,237 | 72,162 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,113,305 | 72,622 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,595,015 | 70,022 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,574,547 | 71,022 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,535,500 | 71,142 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,535,501 | 71,262 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,514,688 | 71,562 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,110,484 | 71,712 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $3,906,693 | 91,441 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,955,123 | 91,441 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,437,444 | 91,723 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,623,018 | 92,766 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,277,039 | 93,617 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,456,019 | 95,752 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,521,985 | 95,402 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,640,381 | 90,994 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,400,146 | 91,494 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||